✦ LIBER ✦

Clinical and pathological evolution of alpha chain disease to immunoblastic lymphoma and response to COMP chemotherapy

✍ Scribed by Rogers, P. ;Hill, I. ;Sinclair-Smith, C. ;Bowie, M.

Publisher: John Wiley and Sons
Year: 1988
Tongue: English
Weight: 542 KB
Volume: 16
Category: Article
ISSN: 0098-1532
DOI: 10.1002/mpo.2950160213

No coin nor oath required. For personal study only.

✦ Synopsis

Clinical and Pathological Evolution of Alpha Chain Disease to lmmunoblastic Lymphoma and Response to COMP Chemotherapy P. Rogers, MRCP (UK), FRCP (C), 1. Hill, MD, FCP (SA), c. Sinclair-Smith, MMED (Path), and M. Bowie, MD, FRCP

A small adolescent with alpha heavy chain mented by serial endoscopy and small intesdisease presenting as malabsorption and tinal biopsy. Clinical and pathological remisevolving to immunoblastic lymphoma is re-sion was obtained by the use of COMP ported. The pathological evolution is docu-combination chemotherapy.

📜 SIMILAR VOLUMES

Relationship of clinical and pathologic

Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer

✍ Csaba Gajdos; Paul Ian Tartter; Alison Estabrook; Michael A. Gistrak; Shabnam Ja 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB 👁 1 views

Phase 2 trial of primary systemic therap

Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : Long-term results from The University of Texas M. D. Anderson Cancer Center Study ID97-099

✍ Ricardo H. Alvarez; Daniel J. Booser; Massimo Cristofanilli; Aysegul A. Sahin; E 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views